Literature DB >> 1107022

Concentration of dipropylacetate in plasma.

P Loiseau, A Brachet, P Henry.   

Abstract

Dipropylacetate is absorbed rapidly and attains a maximum concentration in serum 1 to 3 hr after ingestion. Since its half-life is on the order of 8 to 10 hr, it must be prescribed three times a day, every 8 hr. It reaches a stable concentration in blood within 48 hr after treatment is begun (by contrast with diphenylhydantoin and phenobarbital) and might therefore be useful when seizures must be controlled quickly. The serum concentration can be altered by some other anticonvulsant drugs, but these interactions should be studied in more detail. The serum concentration varies considerably in the course of a day and from one day to the next in the same subject, which makes it difficult to adjust the blood level. Depamide is rapidly transformed in vivo to dipropylacetate.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1107022     DOI: 10.1111/j.1528-1157.1975.tb04743.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  17 in total

1.  Therapeutic drug monitoring.

Authors:  N Buchanan
Journal:  Indian J Pediatr       Date:  1986 Mar-Apr       Impact factor: 1.967

2.  Single and chronic dose pharmacokinetic studies of sodium valproate in epileptic patients.

Authors:  G W Mihaly; F J Vajda; J L Miles; W J Louis
Journal:  Eur J Clin Pharmacol       Date:  1979-08       Impact factor: 2.953

3.  Disposition of valproic acid in patients with liver disease.

Authors:  U Klotz; T Rapp; W A Müller
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953

4.  Transplacental passage and half-life of sodium valproate in infants born to epileptic mothers.

Authors:  S Kaneko; K Otani; Y Fukushima; T Sato; Y Nomura; Y Ogawa
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

5.  Absorption rate and bioavailability of valproic acid and its sodium from rectal dosage forms.

Authors:  F Moolenaar; W J Greving; T Huizinga
Journal:  Eur J Clin Pharmacol       Date:  1980-04       Impact factor: 2.953

Review 6.  Clinical pharmacokinetics of valproic acid.

Authors:  R Gugler; G E von Unruh
Journal:  Clin Pharmacokinet       Date:  1980 Jan-Feb       Impact factor: 6.447

Review 7.  Drug level monitoring in paediatric practice.

Authors:  G W Rylance; T A Moreland
Journal:  Arch Dis Child       Date:  1980-02       Impact factor: 3.791

8.  [Selected clinical aspects of routine monitoring of anticonvulsant concentrations in serum (author's transl)].

Authors:  R Heipertz; H Pilz; K Eickhoff; D Seidel
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1977-12-28

9.  Intra-daily oscillations in dipropylacetic acid plasma levels with two or three daily doses of dipropylacetamide in epileptic patients.

Authors:  F Pisani; E Spina; C Trunfio; A Fazio; G Oteri; R Di Perri
Journal:  Ital J Neurol Sci       Date:  1983-06

Review 10.  Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-02       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.